Researchers have found that the immune system of a sea anemone is capable of selectively distinguishing between different microorganisms and thus protecting beneficial over harmful bacteria – an ability that has only been attributed to vertebrates to date.
An international team has discovered a previously unknown magnetotactic ciliate that pursues an unusual strategy: partnership with two other organisms inside its cell.
Researchers have gained new insights into how the influenza A virus reprograms cellular machinery by tracking molecular interactions directly inside infected cells.
A new artificial intelligence model called Evo 2 can analyze and generate DNA sequences across bacteria, archaea, plants, animals, and other forms of life, marking a major step toward a unified AI system for biology.
The wild plants tucked into yards, sidewalk cracks, ditches and fields offer a treasure trove of biological data. Studying wild plants allows for insights into possible adaptations to disease that no human-designed systems could provide.
Antimicrobial resistance in children is rising globally and will worsen over the next decade, threatening the effectiveness of life‑saving antibiotics, according to a world-first monitoring platform.
Researchers have found that the immune system of a sea anemone is capable of selectively distinguishing between different microorganisms and thus protecting beneficial over harmful bacteria – an ability that has only been attributed to vertebrates to date.
An international team has discovered a previously unknown magnetotactic ciliate that pursues an unusual strategy: partnership with two other organisms inside its cell.
Researchers have gained new insights into how the influenza A virus reprograms cellular machinery by tracking molecular interactions directly inside infected cells.
ABM, a leading international provider of facility, engineering, and infrastructure solutions, has secured a major multi-site services agreement with a leading global life sciences company operating manufacturing facilities across Ireland.
At ASM Microbe 2026, Bruker Corporation’s Microbiology & Infection Diagnostics (BMID) division demonstrated its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.
A new artificial intelligence model called Evo 2 can analyze and generate DNA sequences across bacteria, archaea, plants, animals, and other forms of life, marking a major step toward a unified AI system for biology.
A new study reports a self-powered platform that links electrically assisted forward osmosis (eFO) with a microbial desalination cell (MDC), allowing electricity produced by wastewater-fed microbes to drive nutrient and water recovery.
A research team has developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that enables highly sensitive, portable detection of mosquito-borne viruses, using Chikungunya virus (CHIKV) as a model target.
BugBiome has secured a £500,000 grant from Innovate UK to fund a collaborative project to develop a new biological insecticide to control cabbage stem flea beetles (CSFB) in oilseed rape.
Two researchers are teaming up to build foundational knowledge concerning leishmaniasis, a common, but neglected protozoan parasitic disease. The project combines research into the cell biology of membrane repair with parasitology knowledge.
Researchers creating the first comprehensive fungal EV atlas will investigate vesicles produced by fungi belonging to the Candida, Aspergillus and Cryptococcus genera, while also working to standardise the methods used for their isolation and analysis.